Skip to main content
. 2021 Oct 18;11(10):e044623. doi: 10.1136/bmjopen-2020-044623

Table 5.

Sensitivity analysis: costs and outcome

Excluding unapproached survivors,
N=4468, cost at 28 days
Excluding unapproached survivors,
N=4468, cost at 7 days
Including unapproached survivors,
N=5550, cost at 7 days
NHS costs mean (95% CI) Control £9604 (£9243 to £9967) £4079 (£3982 to £4117) £3669 (£3500 to £3836)
RAPIDO £9572 (£9204 to £9441) £4053 (£3953 to £4153) £3574 (£3378 to £3770)
Difference −£33 (−£549 to £484) −£26 (−£166 to £113) −£95 (−£358 to £168)
28-day survival mean (95% CI) Control 0.78 (0.76 to 0.80) 0.78 (0.76 to 0.80) 0.82 (0.81 to 0.84)
RAPIDO 0.77 (0.75 to 0.79) 0.77 (0.75 to 0.79) 0.81 (0.80 to 0.83)
Difference −0.01 (−0.04 to 0.01) −0.01 (−0.04 to −0.01) −0.01 (−0.03 to 0.01)

NHS, National Health Service; RAPIDO, RAPId Diagnosis on Outcome.